SGI
ONC

Summit Global Investments’s BeOne Medicines Ltd ONC Stock Holding History

Summit Global Investments’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
+728
New +$215K 0.01% 512

Other funds holding ONC

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AG
AIA Group Hong Kong $7.95B AUM 28.94% 1-Year Est. Return

Summit Global Investments's ONC Position: Q2 2026 in Review

Summit Global Investments opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 728 shares worth $207K. The stake represents 0.01% of the portfolio and ranks #512 among its holdings.

77 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Summit Global Investments held 728 shares of BeOne Medicines Ltd worth $207K as of Q2 2026.
  • BeOne Medicines Ltd was a new Summit Global Investments position in Q2 2026.
  • BeOne Medicines Ltd made up 0.01% of Summit Global Investments's portfolio in Q2 2026, its #512 holding.
  • 77 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.